Corby Martin, PhD, FTOS is a clinical researcher and a leader in the development and delivery of novel lifestyle change interventions, including technology-based approaches. He is Professor and Director of the Ingestive Behavior, Weight Management, & Health Promotion Laboratory at Pennington Biomedical Research Center, and he Directs the Human Phenotyping Core of the Center’s Nutrition Obesity Research Center. Dr. Martin is a Fellow of The Obesity Society (FTOS) and he has published over 260 scientific papers and book chapters. Dr. Martin frequently presents at scientific conferences and institutes of higher education, and he is a facilitator for the Commission on Dietetic Registration’s Certificate of Training in Obesity for Pediatrics and Adults. Dr. Martin has received various awards during his career, including the Lilly Scientific Achievement Award in 2013.

The overarching goal of Dr. Martin’s clinical research is to develop tools, programs, and interventions to help people live more fulfilling lives through healthy eating and activity. His research program includes the development of novel methods to assess health behaviors, including the measurement of food intake with smartphone apps. Dr. Martin has integrated these and other assessment platforms into programs to facilitate healthy eating and activity, as well as weight management. These programs have been delivered to adults in clinical research settings and in primary care clinics, and they have been delivered to patients remotely via mobile health technology. Dr. Martin has also developed and delivered weight management programs for children that are delivered in the home environment, in clinic settings, and remotely via mobile health technology. Dr. Martin is a productive clinician scientist and a leader in the weight management field.

Alfred I. Neugut, MD, PhD, is Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, and Director of Global Oncology Research for the Herbert Irving Comprehensive Cancer Center at Columbia.

Dr. Neugut is a medical oncologist with a particular interest in gastrointestinal tract cancers, especially colorectal and gastric cancers. Under the auspices of Columbia’s Medical Scientist Training Program, he received his MD and a Ph.D. in Pathobiology in 1977. His PhD was in the laboratory of Dr. I. Bernard Weinstein, an authority in chemical carcinogenesis, and he studied growth control of cancer cells in vitro. He then trained in Internal Medicine at the Albert Einstein College of Medicine and fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center.

He returned to Columbia for an M.P.H. in Epidemiology in 1983, then joined the faculty at Columbia with appointments in Medicine and Epidemiology. He is a practicing medical oncologist, seeing primarily GI tract malignancies. Dr. Neugut’s research has centered on cancer epidemiology and prevention. He initiated a series of important studies focused on risk factors for the occurrence and recurrence of colorectal adenomatous polyps (adenomas). These studies extended into the use and yield of colonoscopy and fecal occult blood testing for routine screening and diagnosis. An editorial by Dr. Neugut in 1988 was the first to suggest the use of colonoscopy for routine screening of asymptomatic adults, a common practice now. Dr. Neugut’s second major research focus was the occurrence of second malignancies, especially the impact of radiation therapy. He was also the co-PI of the Long Island Breast Cancer Study Project which investigated the high rate of breast cancer on Long Island and generated over 100 papers on environmental risk factors and breast cancer.

At the present time, a significant amount of Dr. Neugut’s research is centered on studying quality of care in the use of chemotherapy and radiotherapy for cancer in the elderly and others. His group has found significant effects of age, race/ethnicity, as well as financial status and the level of co-payments in leading to lower quality care and decreased adherence to prescribed chemotherapy and hormonal therapy. He currently also has several projects ongoing in South Africa on the effect of HIV infection on cancer outcomes.

Dr. Neugut has published over 650 peer reviewed chapters and papers. He has received over $60 million in funding from the National Cancer Institute, American Cancer Society, Department of Defense, and various foundations. He has led two NCI-funded training grants for predoctoral and postdoctoral trainees for over 25 years that have trained over 90 trainees who are now in various academic, government and industrial positions; he has also mentored over 20 K or K equivalent junior faculty award recipients.  He is a recent recipient of the Distinguished Achievement Award of the American Society of Preventive Oncology. He has served on innumerable government grant review committees.

Dr. Michael Parkinson has spent his career advising on public health, preventive medicine, and consumer-driven health plans. Dr. Parkinson is the immediate past president of the American College of Preventive Medicine. He was also the Executive Vice President and Chief Health and Medical Officer of Lumenos, a pioneer of consumer-driven health plans and a subsidiary of Wellpoint. A retired Air Force colonel, his final assignment was as associate director of medical programs and resources in the Office of the Surgeon General. He served on the National Advisory Committee of the Robert Wood Johnson Foundation Health Care Purchasing Institute, was the vice chair of the American Board of Preventive Medicine and was a member of the Residency Review Committee. He is a member of the editorial boards of the American Journal of Preventive Medicine and the American Journal of Medical Quality. He earned his bachelor’s degree from Cornell University, his MD from George Washington University, completed his family practice training at UCLA, and earned his MPH, preventive medicine residency, and chief residency at Johns Hopkins.

Executive Director of Travel Well of Westchester- a Private Clinical, Educational, and Consulting Travel Health Practice since 1998

Director of The Westchester Course: Travel Health Fundamentals, a Continuing Education Short Course since 2001

Ms. Rosselot is an adult nurse practitioner specializing in travel health and certified in occupational health.  She is a graduate of Dickinson College, Cornell University-NY Hospital School of Nursing, Columbia University School of Nursing, and the Columbia Mailman School of Public Health. She is a founding member, fellow, past president , and current vice president for special projects of the American Travel Health Nurses Association (ATHNA). Ms. Rosselot has been active in the International Society of Travel Medicine (ISTM) since its founding and currently chairs its Continuous Professional Development Committee. She is an ISTM fellow and second recipient of the ISTM Distinguished Nurse Leadership Award. She is a fellow of the Faculty of Travel Medicine, Royal College of Physicians and Surgeons (Glasg) and the American Academy of Nurse Practitioners. Ms. Rosselot has authored sections in the CDC Health Information for International Travel and travel health chapters in the Keystone, Jong, and Vaughn and Viera textbooks. She teaches courses for CDC, the CIA, Smithsonian, the Canadian Federal Government, numerous corporations, and U.S. universities. Recently she chaired the group that achieved ANA specialty recognition for travel health nursing and was lead author of Travel Health Nursing: Scope and Standards of Practice, 1st ed. and the new Code of Ethics for Travel Health Nursing. In May 2021, Ms. Rosselot received the Distinguished Alumni Award from NY Hospital-Cornell University School of Nursing. Currently she is the athna.org editor and a co-author of two travel health white papers in development: Travel Health Services in the University Setting: Best Practices and Pretravel Guidance for Humanitarian Workers. Ms. Rosselot also chairs the task force to develop a U.S. certification for the specialty of travel health nursing. She lives in Briarcliff Manor, NY with her husband and daughter and loves to read medical thrillers and travel whenever given the opportunity.

Dr. Rundle is a Tenured Professor of Epidemiology at Columbia’s Mailman School of Public Health and Co-Director of the Department’s Social and Spatial Epidemiology Unit.  His research largely focuses on the causes of childhood and adult obesity and the cancer related consequences of obesity, particularly for prostate cancer.  For the past 15 years he has directed childhood obesity research for the Columbia Center for Children’s Environmental Health. As Co-Director of the Built Environment and Health Research Group, Dr. Rundle studies how neighborhood built, social, economic and medical environments impact health, health behaviors and medical practice.  His work on links between neighborhood built and social environments and diet, physical activity and obesity has influenced the New York City Active Design Guidelines, the New York City FRESH program to bring supermarkets to underserved neighborhoods and the International WELL Building Institutes’ WELL Building and WELL Community design standards.

He and his collaborators have been central to Columbia University’s COVID-19 response and planning work.  He and his team built Columbia’s online interactive mapping (https://tinyurl.com/beh-columbia-maps) and data visualization tools (https://cuepi.shinyapps.io/COVID-19/) for COVID-19 case and infection forecasts, community vulnerability and health care system capacity.  These tools have been used in COVID-19 response by the U.S. Army Corps of Engineers, the Pentagon, the U.S. Air Force, the Federal Reserve Board, the CDC, major US corporations and numerous state and county public health and planning agencies. He directed COVID-19 informatics and analyses for Stamford Connecticut’s Department of Health and advises a large US financial services company on return-to-work planning for its locations across the US.

He has served on EHE’s Medical and Scientific Advisory Boards for over 15 years and has directed the company’s efforts to conduct clinical and public health research.